All Subjects
Light
collapse
Pharma and Biotech Industry Management
Intro to Pharma, Biotech & Medical Devices
Drug & Device Development Process
Regulatory Pathways & Compliance
IP Protection & Patent Strategies
R&D Investment Decisions in Pharma & Biotech
Pricing and Market Access in Healthcare
Value-Based Healthcare Reimbursement
Global Markets & International Regulations
Emerging Tech Impact on Pharma Industry
Healthcare Innovation Ethics
Healthcare Innovation & Affordability Balance
Industry Case Studies & Applications
Future Challenges in Pharma and Biotech
Course Review and Final Exam
Glossary
All Key Terms
Pharma and Biotech Industry Management
Browse all Pharma and Biotech Industry Management Key Terms
ALL
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
18-month publication
21 CFR Part 210
340B Drug Pricing Program
3D printing
3D printing in medical devices
510(k) clearance
A
Accelerated Approval Pathway
Access Programs
Access to essential medicines
Accountable Care Organizations
Accountable Care Organizations (ACOs)
Active Pharmaceutical Ingredients (APIs)
Ad valorem tariffs
Adaptation of treatment protocols
Adaptive trial designs
Additive manufacturing
Advanced drug delivery systems
Adverse Drug Reaction
Adverse event reporting
Adverse Event Reporting Systems
Adverse selection
Advisory Panel
Affordable Care Act
AI Ethics
AI in Drug Discovery
AI in Pharmacovigilance
Ai-assisted surgery
Ai-driven drug discovery
Ai-powered matching algorithms
Algorithmic bias
Alignment of objectives
All of Us Research Program
Alzheimer's disease
American Pharmaceutical Association
American Telemedicine Association
Analytical methods validation
Analytical similarity
ANDA
Angel investors
Anti-kickback statute
Antibiotic resistance
Antimicrobial peptides
Antitrust scrutiny
Artificial intelligence
Attrition rate
Augmented reality in medicine
Authorized Generics
Automation
B
Bacteriophage therapy
Balanced Scorecard
Batch Records
Belmont Report
Benchmarking against competitors
Beneficence
Big data analytics
Big Pharma
Bioavailability
Biocompatible Materials
Biodefense strategy
Biodegradable materials
Bioequivalence
Bioequivalence studies
Bioinformatics
Biologic therapies
Biologics exclusivity
Biologics market growth
Biologics Price Competition and Innovation Act
Biomarkers
Biomaterials
Bioprinting
Bioprinting technology
Biosimilar biologics
Biosimilar development
Biosimilar portfolios
Biosimilars
1
2
3
4
5
…
14
About Us
About Fiveable
Blog
Careers
Testimonials
Code of Conduct
Terms of Use
Privacy Policy
CCPA Privacy Policy
Resources
Cram Mode
AP Score Calculators
Study Guides
Practice Quizzes
Glossary
Crisis Text Line
Request a Feature
Report an Issue
Stay Connected
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
About Us
About Fiveable
Blog
Careers
Testimonials
Code of Conduct
Terms of Use
Privacy Policy
CCPA Privacy Policy
Resources
Cram Mode
AP Score Calculators
Study Guides
Practice Quizzes
Glossary
Crisis Text Line
Request a Feature
Report an Issue
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Back
Practice Quiz
Guides
Glossary
Practice Quiz
Guides
Next